Insulin Resistance: The Link Between Obesity and Cardiovascular Disease

Medical Clinics of North America

Volumn 95, Issue 5, 2011, Pages 875-892

  Reaven, Gerald M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index; Cardiovascular disease; Insulin resistance; Insulin mediated glucose uptake; Obesity; Waist circumference

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BODY FAT DISTRIBUTION; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; FITNESS; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; STEADY STATE; UNITED STATES; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADIPOSITY; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN RESISTANCE; LIPIDS; OBESITY; OVERWEIGHT; PHYSICAL FITNESS; PREVALENCE; UNITED STATES; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 80051748943     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2011.06.002     Document Type: Review

References (78)

1. Flegal K.M., Carroll M.D., Ogden C.L., et al. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002, 288:1723-1727.
2. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004, 291:2847-2850.
3. Allison D.B., Fontaine K.R., Manson J.E., et al. Annual deaths attributable to obesity in the United States. JAMA 1999, 282:1530-1538.
4. Fontaine K.R., Redden D.T., Wang C., et al. Years of life lost due to obesity. JAMA 2003, 289:187-193.
5. Hu F.B., Willett W.C., Li T., et al. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med 2004, 351. 2964-703.
6. Calle E.E., Thun M.J., Petrelli J.M., et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999, 341:1097-1105.
7. Yan L.L., Daviglus M.L., Liu K., et al. Midlife body mass index and hospitalization and mortality in older age. JAMA 2006, 295:190-198.
8. West K.M., Kalbfleisch J.M. Influence of nutritional factors on prevalence of diabetes. Diabetes 1971, 20:99-108.
9. Havlik R.J., Hubert H.B., Fabsitz R.R., et al. Weight and hypertension. Ann Intern Med 1983, 98:855-859.
10. Wilson P.W., D'Agostino R.B., Sullivan L., et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
11. Manson J.E., Skerrett P.J., Greenland P., et al. The escalating pandemics of obesity and sedentary lifestyle. Arch Intern Med 2004, 164:249-258.
12. Flegal K.M., Graubard B.I., Williamson D.F., et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005, 293:1861-1867.
13. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 2005, 293:1868-1874.
14. Rosenthal M., Haskell W.L., Solomon R., et al. Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 1983, 32:408-411.
15. Bogardus C., Lillioja S., Mott D., et al. Relationship between obesity and maximal-insulin stimulated glucose uptake in vivo and in vitro in Pima Indians. J Clin Invest 1984, 73:800-805.
16. Bogardus C., Lillioja S., Mott D.M., et al. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985, 248:E286-E291.
17. Soman V.R., Koivisto V.A., Deibert D., et al. Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med 1978, 301:1200-1204.
18. Koivisto V.A., Yki-Jarvinen H., DeFronzo R.A. Physical training and insulin sensitivity. Diabetes Metab Rev 1986, 445-481.
19. Goodyear L.J., Kahn B.B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998, 49:235-261.
20. Wessel T.R., Arant C.B., Olson M.B., et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA 2004, 292:1179-1187.
21. Weinstein A.R., Sesso H.D., Lee I.M., et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA 2004, 292:1188-1194.
22. Li T.Y., Rana J.S., Manson J.E., et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation 2006, 31:499-506.
23. Sullivan P.W., Morrato E.H., Ghushchyan V., et al. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care 2005, 28:1599-1603.
24. Rana J.S., Li T.Y., Manson J.E., et al. Adiposity compared with physical inactivity and risk of type 2 diabetes in women. Diabetes Care 2007, 30:53-58.
25. Olefsky J.M., Reaven G.M., Farquhar J.W. Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism. J Clin Invest 1974, 53:64-76.
26. Ruderman N.B., Schneider S.H., Berchtold P. The " metabolically-obese," normal weight individual. Am J Clin Nutr 1981, 1617-1621.
27. Ferrannini E., Natali A., Bell P., et al. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997, 100:1166-1173.
28. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2002, 285:2486-2497.
29. Alberti K.G., Zimmet P., Shaw J. The metastatic syndrome-a new worldwide definition. Lancet 2004, 366:1059-1061. for the IDF Epidemiology Task Force Consensus Group.
30. Ford E.S., Mokdad A.H., Giles W.H. Trends in waist circumference among U.S. adults. Obes Res 2003, 11:1223-1231.
31. Pei D., Jones C.N., Bhargava R., et al. Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 1994, 37:843-845.
32. Shen S.-W., Reaven G.M., Farquhar J.W. Comparison of impedance to insulin mediated glucose uptake in normal and diabetic subjects. J Clin Invest 1970, 49:2151-2160.
33. Greenfield M.S., Doberne L., Kraemer F.B., et al. Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 1981, 30:387-392.
34. Farin H.M., Abbasi F., Reaven G.M. Body mass index and waist circumference both contribute to differences in insulin-mediated glucose disposal in nondiabetic adults. Am J Clin Nutr 2006, 83:47-51.
35. Abate N., Garg A., Peshock R.M., et al. Relationships of generalized and regional adiposity to insulin sensitivity in man. J Clin Invest 1995, 96:88-98.
36. Cefalu W.T., Wang Z.Q., Werbgel S., et al. Contribution of visceral fat to the insulin resistance of aging. Metabolism 1995, 44:954-959.
37. Macor C., Ruggeri A., Mazzonetto P., et al. Visceral adipose tissue impairs insulin secretion and sensitivity, but not energy expenditure in obesity. Metabolism 1997, 46:123-129.
38. Goodpaster B.H., Thaete J.A., Simoneau J.A., et al. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997, 46:1579-1585.
39. Banerji M.A., Faridi N., Atluri R., et al. Body composition, visceral fat, leptin and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999, 84:137-144.
40. Kelley D.E., Thaete F.L., Troost F., et al. Subdivisions of subcutaneous abdominal tissue and insulin resistance. Am J Physiol Endocrinol Metab 2000, 278:E941-E948.
41. Sites C.K., Calles-Escandon J., Brochu M., et al. Relation of regional fat distribution to insulin sensitivity in postmenopausal women. Fertil Steril 2000, 73:61-65.
42. Brochu M., Starling R.D., Tchernof A., et al. Visceral adipose tissue is an independent correlate of glucose disposal in older postmenopausal women. J Clin Endocrinol Metab 2001, 85:2378-2384.
43. Goran M.I., Bergman R.N., Gower B.A. Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res 2001, 423-431.
44. Rendell M., Hulthen U.L., Tornquist C., et al. Relationship between abdominal fat compartments and glucose and lipid metabolism in early postmenopausal women. J Clin Endocrinol Metab 2001, 86:744-749.
45. Purnell J.Q., Kahn S.E., Schwartz R.S., et al. Relationship of insulin sensitivity and apoB levels to intra-abdominal fat in subjects with combined hyperlipidemia. Arterioscler Thromb Vasc Biol 2001, 21:567-572.
46. Raji A., Seeley E.W., Arky R.A., et al. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001, 86:5366-5371.
47. Ross R., Aru J., Freman J., et al. Abdominal obesity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002, 282:E657-E663.
48. Ross R., Freeman J., Hudson R., et al. Abdominal obesity, muscle composition and insulin resistant in premenopausal women. J Clin Endocrinol Metab 2002, 87:5044-5051.
49. Cnop M., Landchild M.J., Vidal J., et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations. Diabetes 2002, 51:1005-1015.
50. Cruz M.L., Bergman R.N., Goran M.I. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care 2002, 25:1631-1636.
51. Gan S.K., Krikeos A.D., Poynten A.M., et al. Insulin action, regional fat, and myocyte lipid; altered relationships with increased adiposity. Obes Res 2003, 11:1295-1305.
52. Tulloch-Reid M.K., Hanson R.L., Sebring N.G., et al. Both subcutaneous and visceral adipose tissues correlate highly with insulin resistance in African Americans. Obes Res 2004, 1352-1359.
53. Rattarasarn C., Leelawattan R., Soonthornpun S., et al. Gender differences of regional abdominal fat distribution and their relationships with insulin sensitivity in healthy and glucose-intolerant Thais. J Clin Endocrinol Metab 2004, 89:6266-6270.
54. Raji A., Gerhard-Herman M.D., Warren M., et al. Insulin resistance and vascular dysfunction in nondiabetic Asian Indians. J Clin Endocrinol Metab 2004, 89:3965-3972.
55. Bush N.C., Darnell B.E., Oster R.A., et al. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. Diabetes 2005, 54:2772-2778.
56. Janssen I., Heymsfield S.B., Allison D.B., et al. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal, subcutaneous, and visceral fat. Am J Clin Nutr 2002, 75:683-688.
57. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
58. Reaven G.M. The insulin resistance syndrome. Curr Atheroscler Rep 2003, 5:364-371.
59. McLaughlin T., Abbasi F., Carantoni M., et al. Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 1999, 84:578-581.
60. Jones C.N., Abbas F., Carantoni M., et al. Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 2000, 278:E501-E508.
61. McLaughlin T., Abbasi F., Kim H.-S., et al. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 2001, 50:795-800.
62. McLaughlin T., Abbasi F., Lamendola C., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 2002, 106:2908-2912.
63. McLaughlin T., Abbasi F., Cheal K., et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003, 139:802-809.
64. McLaughlin T., Abbasi F., Lamendola C., et al. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med 2007, 167:642-648.
65. McLaughlin T., Stuhlinger M., Lamendola C., et al. Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin resistant women and fall with weight loss. J Clin Endocrinol Metab 2006, 91:1896-1900.
66. Genuth S., Alberti K.G., Bennett P., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
67. Yeni-Komshian H., Carantoni M., Abbasi F., et al. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 2000, 23:171-175.
68. Yip J., Facchini F.S., Reaven G.M. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998, 83:2773-2776.
69. Facchini F.S., Hua N., Abbasi F., et al. Insulin resistance as a predictor of age- related diseases. J Clin Endocrinol Metab 2001, 86:3574-3578.
70. Abbasi F., Reaven G.M. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002, 51:235-237.
71. Kim S.H., Abbasi F., Reaven G.M. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004, 27:1998-2002.
72. McLaughlin T., Reaven G., Abbasi F., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 2005, 96:399-404.
73. Miller G.J., Miller N.E. Plasma high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1975, 1:16-19.
74. Carlson L.A., Bottiger L.E., Ahfeldt P.E. Risk factors for myocardial infarction in the Stockholm prospective study: a 14-year follow-up focusing on the role of plasma triglycerides and cholesterol. Acta Med Scand 1979, 206:351-360.
75. Castelli W.P., Garrison R.J., Wilson P.W., et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA 1986, 256:2385-2387.
76. Hokanson J.E., Austin M.A. Plasma triglyceride level in a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996, 3:213-219.
77. Galuska D.A., Will J.C., Serdula M.K., et al. Are health care professionals advising obese patients to lose weight?. JAMA 1999, 282:1576-1578.
78. Zavaroni I., Bonini L., Gasparini P., et al. Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. Metabolism 1999, 48:989-994.